MedPath

H. Lee Moffitt Cancer Center and Research Institute, Inc.

H. Lee Moffitt Cancer Center and Research Institute, Inc. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic Tumors

Terminated
Conditions
Pancreatic Tumors
Interventions
Procedure: EUS Guided Fine Needle Aspiration
Procedure: EUS Guided EchoBrush Sampling
First Posted Date
2011-10-19
Last Posted Date
2013-02-15
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
21
Registration Number
NCT01455311
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects

Phase 1
Completed
Conditions
Pancreatic Cancer
Interventions
Drug: Vitamin E δ-Tocotrienol
First Posted Date
2011-10-12
Last Posted Date
2016-07-07
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
18
Registration Number
NCT01450046
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects

Phase 1
Completed
Conditions
Pancreatic Cancer
Interventions
Drug: Vitamin E δ-Tocotrienol
First Posted Date
2011-10-05
Last Posted Date
2016-04-11
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
18
Registration Number
NCT01446952
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC

Phase 2
Terminated
Conditions
Melanoma
First Posted Date
2011-09-21
Last Posted Date
2019-12-20
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
14
Registration Number
NCT01437605
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

A Study of Axitinib in Advanced Carcinoid Tumors

Phase 2
Completed
Conditions
Carcinoid Tumor
Interventions
First Posted Date
2011-09-15
Last Posted Date
2018-10-02
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
30
Registration Number
NCT01435122
Locations
🇺🇸

University of California San Francisco (UCSF), San Francisco, California, United States

🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer

Not Applicable
Withdrawn
Conditions
Pancreatic Tumor
Interventions
Radiation: Stereotactic Body Radiation Therapy (SBRT)
Radiation: Tissue, Blood, Research Imaging (TBRI)
First Posted Date
2011-09-15
Last Posted Date
2017-02-23
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Registration Number
NCT01434550

Phase I Trial of Combination of FOLFIRI and SOM 230

Phase 1
Completed
Conditions
Gastrointestinal Tumor
Interventions
Drug: SOM230C LAR
Drug: FOLFIRI Infusion
First Posted Date
2011-09-14
Last Posted Date
2015-12-24
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
16
Registration Number
NCT01434069
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer

Phase 1
Completed
Conditions
Lung Cancer
Adenocarcinoma
Interventions
Biological: Phase I - GM.CD40L.CCL21 Vaccinations
Biological: Phase II - GM.CD40L cells Vaccinations
Biological: Phase II - GM.CD40L.CCL21 Vaccinations
First Posted Date
2011-09-13
Last Posted Date
2019-08-06
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
73
Registration Number
NCT01433172
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide

Phase 1
Completed
Conditions
Myeloma
Interventions
First Posted Date
2011-09-13
Last Posted Date
2017-05-23
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
80
Registration Number
NCT01432600
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

🇺🇸

University of California San Francisco, San Francisco, California, United States

🇺🇸

Mount Sinai School of Medicine, The Tisch Cancer Institute, New York, New York, United States

Study of Gardasil in Mid-Adult Males (MAM)

Phase 2
Completed
Conditions
Human Papillomavirus
Interventions
Biological: Gardasil
First Posted Date
2011-09-13
Last Posted Date
2021-09-16
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
150
Registration Number
NCT01432574
Locations
🇲🇽

National Institute of Public Health, Mexico, Cuernavaca, Mexico

🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath